DESCRIPTION.
State the application's broad, long-term objectives and specific aims, making
reference to the health relatedness of the project. Describe concisely the
research design and methods for achieving these goals. Avoid summaries of past
accomplishments and the use of the first person. This descnption is meant to
serve as a succinct and accurate description of the proposed work when
separated from the application. If the application is funded, this description,
as is, will become public information. Therefore, do not include
proprietary/confidential information. DO NOT EXCEED THE SPACE PROVIDED.
The increased prevalence of
type 2 diabetes among children is attributed to a simultaneous increase in
childhood obesity. Most children are diagnosed during puberty. Ethnic minority
children, such as Native Americans, African Americans, and Hispanics, are disproportionately
affected. Asians represent a rapidly growing minority group in the
The overall aim of this study is to better
understand in children the metabolic changes that precede the development of
type 2 diabetes, and the influence of Asian ethnicity on diabetes risk. The
specific aims of this project are: 1) to describe the metabolic changes and
adipose factors that are associated. with the insulin resistance metabolic
syndrome in prepubertal children; 2) to describe the relationship between
pancreatic islet B-cell function and family history of type 2 diabetes; 3) to
describe changes in these factors as children progress through puberty; 4) to
describe the relationship of diet and physical activity to the metabolic and
adipose factors; and 5) to describe the relationship between Japanese ancestry
and metabolic, adipose, and insulin secretion factors. To accomplish these goals, a longitudinal cohort study of 450
prepubertal (8-10 year old) nondiabetic Japanese-American and Caucasian
children is proposed. Measurements at baseline and 2 year follow-up will
include: lipids and LDL particle size, insulin, C-peptide, proinsulin, glucose
tolerance and insulin secretion determined by an intravenous glucose tolerance
test, plasminogen activator inhibitor-1, fibrinogen, C-reactive protein,
insulin-like growth factor-1 and insulin-like growth factor binding protein-3,
body composition by DEXA, and intra-abdominal fat by MRI.
This study will
improve the understanding of how pubertal changes in metabolic and adipose
factors affect diabetes risk in Asian and Caucasian children.
PERFORMANCE SITE(S) (organization, city, state)
Children's
Hospital and
Veteran's
KEY PERSONNEL See instructions on Page 11. Use continuation pages as needed to provide
the required information in the format shown below.
Name Organization Role
on Project
The increased prevalence of type 2
diabetes among children is attributed to a simultaneous increase in childhood
obesity. Many ethnic minority groups are
known to be at increased risk for type 2 diabetes in adulthood, yet relatively
little is known about the risk factors that precede this condition among ethnic
minority youth. Asians represent a
rapidly growing minority group in the
The long-term aim of this study is to better understand in
children the metabolic changes that precede the development of type 2 diabetes,
and the influence of Asian ethnicity on diabetes risk. This proposal extends the Japanese American
Community Diabetes Study to create a separate, longitudinal study of
prepubertal children of varying proportions of Japanese ancestry (ranging from
0 to 100%) who will be followed into and through puberty.
Specific Aim
1: To
describe in prepubertal (8-10 years), nondiabetic children the metabolic and
adipose factors that are associated with the insulin resistance metabolic
syndrome. These include fasting plasma
lipids (cholesterol, triglycerides, HDL-cholesterol, and LDL-cholesterol), LDL
particle size, plasminogen activator inhibitor-1 (PAI-1), fibrinogen,
C-reactive protein, glucose, insulin, C-peptide, and proinsulin; glucose
tolerance assessed as glucose disappearance rate constant (KG)
during an intravenous glucose tolerance test; body composition by DEXA; body
fat distribution by MRI; and body mass index.
Hypothesis
1: Features of the metabolic syndrome are
evident in some prepubertal children.
Specific Aim
2: To
assess variation in pancreatic islet ß-cell function by measuring fasting
plasma insulin, C-peptide, proinsulin, and acute insulin response to glucose
(AIRg) by an intravenous glucose tolerance test.
Hypothesis
2:
Glucose-stimulated insulin secretion is lower among children with a family
history of type 2 diabetes.
Specific Aim
3: To
describe the changes in these factors as children progress through and complete
puberty. Tanner staging is used and
plasma testosterone, estradiol, DHEA-S, IGF-1, and IGFBP-3 are measured.
Hypothesis
3:
Puberty is associated with changes in body fat distribution and metabolic
parameters in a direction consistent with higher risk of glucose intolerance
and cardiovascular disease.
Specific Aim
4: To
describe the relationship of lifestyle factors (diet and physical activity) to
the metabolic and adipose factors, and changes therein.
Hypothesis
4: Diet
and physical activity are important predictors of adiposity and metabolic
changes in children.
Specific Aim
5: To
describe the relationship of proportion of Japanese ancestry to the metabolic
and adipose factors, and changes therein.
Hypothesis
5: A
higher proportion of Japanese ancestry is associated with a greater
predisposition to the metabolic syndrome and diminished insulin secretion.
B. BACKGROUND AND SIGNIFICANCE
B1. EPIDEMIOLOGY OF TYPE 2 DIABETES IN CHILDREN
· Increasing Incidence of
Childhood Type 2 Diabetes.
The natural history of type 2 diabetes is
characterized by both insulin resistance and islet ß-cell dysfunction, and
hyperglycemia usually develops gradually.
Thus, it is relatively asymptomatic in its early stages. Type 2 diabetes is often associated with
obesity. In contrast, the
pathophysiology of type 1 diabetes is completely different. Type 1 diabetes results from insulin
deficiency due to autoimmune islet ß-cell destruction, and is thus often
associated with autoantibodies to islet ß-cell components and contents. Unlike type 2 diabetes, the onset of type 1
diabetes is often precipitous with prominent diabetic symptoms, often including
ketoacidosis. The majority of children
with diabetes have type 1. Prior to the
1990's, there were only a few reports of childhood type 2 diabetes, which has
therefore been considered a disease of adults.
However, although population-based data are sparse, there is consensus
that the incidence of type 2 diabetes among children and adolescents has
increased in recent years [1-4]. This trend is attributed to increasing rates
of childhood obesity and physical inactivity.
In
· Lifestyle and Childhood Obesity
The prevalence of childhood obesity in the
· Risk Factors for Childhood
Type 2 Diabetes
In general, the risk factors for type 2 diabetes
among children are similar to those reported for adults. Adolescents are affected more often than
younger children, with an average age at diagnosis of about 13.5 years [2]. This suggests that body composition and/or
metabolic changes during puberty play an important role in the onset of
diabetes. About 95% of affected children
are ³ 85th age- and sex-specific percentile for
body mass index (BMI), and most have a family history of type 2 diabetes [2, 5]. A strong association between acanthosis
nigricans and childhood type 2 diabetes has also been reported [2, 5, 6]. As with adults, Hispanic [17, 18], African-American [5, 6], and Native-American [19, 20] children appear to be
disproportionately affected. Several studies have shown a gender discrepancy,
with more girls affected than boys [2], an observation that is
consistent with the earlier onset of puberty in girls.
· Lack of Information on Asian-American
Children Despite Increased Risk in Asian Adults.
There are little population-based health data
available on Asian Americans, and this is especially true for Asian-American
children. Yet Asians are the fastest
growing ethnic minority population in the United States [21]. Despite having a lower average BMI than
Caucasians, South Asian adults living in the United Kingdom are 4 times as
likely to have diabetes [22]. The prevalence of self-reported, physician
diagnosed diabetes in residents of Hawaii is lowest in Caucasians (2.7%),
highest in Japanese Americans (6.4%), and intermediate in those of Chinese
(3.5%), Filipino (4.6%), and Native Hawaiian (4.7%) ancestry [23]. The increased risk of diabetes among Asians
has been associated with a propensity for central or visceral adiposity [24-26]. Thus, there is reason to suspect that
Asian-American children, particularly those who have adopted a western
lifestyle, are at increased risk for diabetes.
The only published data on the incidence of type 2
diabetes in Asian children comes from Japan [11]. In a population-based study from Tokyo,
asymptomatic schoolchildren were periodically screened for glucosuria, and an
oral glucose tolerance test was performed on those who screened positive. Among primary school children, diabetes
incidence increased tenfold from 0.2/100,000 in 1976-1980 to 2.0/100,000 in
1991-1995. Among junior high school
children, diabetes prevalence increased from 7.3/100,000 to 13.9/100, 000
during the same years. Diabetes trends
mirrored upward trends in body mass index and consumption of animal fats. Thus, it appears that vulnerability to diabetes
among Asians begins in childhood. It is
likely that the problem is even greater in the United States, where the
prevalence of childhood obesity exceeds 20% [9].
B2. PATHOPHYSIOLOGY OF TYPE 2 DIABETES
The pathophysiology of
hyperglycemia in type 2 diabetes includes both abnormalities in islet ß-cell
function and development of insulin resistance.
The latter is associated with overall obesity as well as with increased
accumulation of body fat centrally.
B2a. ß-cell Dysfunction
· Abnormal Glucose-Stimulated Insulin Secretion
It is well established that
even with obesity and insulin resistance, euglycemia is maintained in the
presence of normal ß-cells, although at the expense of hyperinsulinemia. As is true for adults, normoglycemic obese
children and adolescents are insulin resistant and hypersecrete insulin [27-30]. Japanese adults with impaired glucose tolerance demonstrate both
impaired insulin sensitivity and hypersecretion of insulin, particularly if
they are obese [31]. Despite hypersecretion of
insulin, however, individuals with impaired glucose tolerance exhibit reduced
glucose-stimulated insulin secretion relative to the degree of insulin
resistance. Furthermore, the defect is
even greater in persons who have type 2 diabetes. Thus, in the setting of insulin resistance,
plasma glucose levels are more likely to reach values diagnostic of diabetes
among individuals with abnormal ß-cell function who are unable to maintain
adequate insulin secretion to compensate for insulin resistance. Although there is evidence that insulin
resistance precedes the decline in insulin secretion among some individuals at
high risk for type 2 diabetes [32], other reports suggest that impaired insulin secretion precedes or
accompanies the development of insulin resistance [33]. In Japanese adults with
impaired glucose tolerance, low insulin secretion predicts progression to
diabetes [34, 35].
The causes of impaired glucose-stimulated
insulin secretion are not fully understood.
Among adults, aging is associated with a gradual decline in insulin
secretion, and may explain the increased incidence of type 2 diabetes in the
elderly [27, 36]. Insulin secretion capacity may
also be genetically determined. For
example, insulin secretion is 65% lower among nondiabetic individuals who have
an identical twin with type 2 diabetes, compared to other nondiabetic
individuals [37]. Other studies have demonstrated
reduced insulin secretion among first-degree relatives of patients with type 2
diabetes compared to individuals of similar age and BMI without a family
history of diabetes [38]. Thus, it is plausible that
ethnic variation in diabetes prevalence may be partly explained by genetic
determinants of insulin secretion.
· Abnormal Processing of Proinsulin to Insulin
Another measure of islet
ß-cell dysfunction is incomplete processing of proinsulin to insulin. Within the secretory granules of the ß-cell,
two enzymes (prohormone convertases 2 and 3) process proinsulin to intermediate
proinsulin split products and then to insulin plus C-peptide [39]. If this process is abnormal,
increased amounts of proinsulin and intermediate split products are present in
plasma. Depending on the assay used to
measure proinsulin, this increase may be measured as the plasma concentration
of either proinsulin or of proinsulin plus intermediates. Individuals with type 2 diabetes secrete
excess proinsulin [40, 41]. Both the concentration of
proinsulin and the proportion of immunoreactive insulin attributable to
proinsulin are increased. Moreover, the
magnitude of the proinsulin to insulin ratio is inversely correlated with
insulin secretion in patients with type 2 diabetes [42]. Since the orderly cleavage of
proinsulin appears intact in type 2 diabetes, the excess release of
incompletely processed proinsulin seems to be the result of either slower
conversion or reduced storage time in the ß-cell [40].
This abnormality of
proinsulin secretion precedes the diabetic state. Individuals with impaired glucose tolerance
have an elevated proinsulin to insulin ratio compared to normoglycemic
individuals [43], and fasting proinsulin levels predict the development of diabetes [44-46]. Among normoglycemic
individuals, the proinsulin level and the proinsulin to insulin ratio are
inversely correlated with insulin secretion, independent of age, gender, body
mass index, waist to hip ratio, and insulin sensitivity [47]. Although it has been reported
that proinsulin levels increase following hemipancreatectomy, suggesting that
this may be a response to increased ß-cell demand [48], insulin resistance induced
by administration of nicotinic acid is not accompanied by a disproportionate
increase of proinsulin [49, 50]. Thus elevated proinsulin
levels found with type 2 diabetes appear not to be simply a response of the
ß-cell to insulin resistance, but probably represents an intrinsic abnormality
of the ß-cells.
B2b. Obesity and Insulin Resistance
Increased adiposity, as measured by BMI, triceps
skinfold thickness, and dual-energy x-ray
absorptiometry (DEXA), is associated with increased fasting insulin levels in
prepubertal and postpubertal children [29, 51-53]. As mentioned previously, normoglycemic
obese children and adolescents are insulin resistant and hypersecrete insulin [27-30]. Thus, the association between obesity and
insulin resistance seems to be well established in children.
· Effect of Pubertal Stage
A recent study demonstrated transient insulin
resistance (measured by euglycemic clamp) during early puberty (Tanner stages 2
to 3), returning to prepubertal levels by late puberty [51]. Girls were more insulin resistant than boys
regardless of pubertal stage in this study.
These findings are consistent with prior studies demonstrating lower
insulin levels in prepubertal children compared to midpubertal children [54, 55]. Both sex steroids and growth hormone (and
peptides related to growth hormone action) have been implicated as causing
insulin resistance during puberty since both rise during puberty [56-62]. Growth hormone effects are now more commonly
assessed by measurements of insulin-like growth factor-1 (IGF-1) [63], the peripheral hormone
that mediates many of the effects of growth hormone, and insulin-like growth
factor binding protein-3 (IGFBP-3) [64].
· Effect of Ethnicity
The effect of ethnicity has been most extensively
studied in African-American and Caucasian children. In prepubertal children, insulin sensitivity
(determined by a tolbutamide-modified frequently sampled intravenous glucose
tolerance test with minimal modeling) was 42% lower among African-American
children compared to Caucasian children [52]. This same group reported higher fasting
insulin levels in African American prepubertal children [53]. African-American adolescent girls have higher
fasting insulin levels and decreased hepatic insulin clearance compared to
Caucasians [65]. Arslanian and colleagues also showed
decreased insulin sensitivity and increased insulin secretion among
African-American adolescents compared to Caucasians using a 2-hour
hyperglycemic clamp [66]. In contrast, others reported that insulin
resistance (measured by euglycemic clamp) was greater in pubertal Caucasian
than African-American boys, but did not differ by ethnicity in pubertal girls [51]. It remains unclear if these discrepant
findings are due to differences in methodology or pubertal stage of the
subjects.
B2c. Visceral Adiposity and Features of the Insulin
Resistance Syndrome.
· Adults
The terms insulin resistance syndrome, metabolic
syndrome, and syndrome X refer to a constellation of metabolic findings associated
with increased cardiovascular disease risk in adults [67-69]. These metabolic factors include
hyperinsulinemia, insulin resistance, hypertension, dyslipidemia (elevated
triglycerides, low HDL cholesterol, and increased amounts of small, dense LDL),
and obesity. While not part of the
original description, increases in hemostatic factors [70-72] and inflammatory markers
such as C-reactive protein [73-75] are also associated with
the insulin resistance syndrome. In
adults, the insulin resistance syndrome is more strongly associated with
central adiposity (particularly visceral or intra-abdominal fat) than total
body adiposity or subcutaneous fat [76-85]. Since intra-abdominal fat deposition is
influenced by gender and menopausal status [86-88], it is presumed that sex
hormones are involved in body fat distribution.
Thus, puberty may be an important milestone in determining body fat
distribution.
· Prepubertal Children
A few research groups have studied the metabolic effects of intra-abdominal (visceral) fat in prepubertal children. Visceral adiposity is associated with elevated fasting insulin and triglycerides in prepubertal children [52, 89, 90]. Incremental 30-minute insulin measured during an oral glucose tolerance test is associated with visceral fat in Caucasian, but not African-American children [53]. Insulin sensitivity (measured by a tolbutamide-modified, frequently sampled intravenous glucose tolerance test with minimal modeling), however, is associated with total fat mass but not visceral fat